NCT02910999View on ClinicalTrials.gov

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy

CompletedOBSERVATIONAL
Enrollment

868

Participants

Timeline

Start Date

August 9, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Non-Small Cell Lung Cancer
Trial Locations (1)

60590

Local Institution - 0001, Frankfurt

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY